Peregrine Capital Management LLC lessened its holdings in shares of Healthequity Inc (NASDAQ:HQY) by 3.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 210,815 shares of the company’s stock after selling 6,947 shares during the period. Peregrine Capital Management LLC owned 0.30% of Healthequity worth $12,369,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in HQY. State of Michigan Retirement System raised its holdings in Healthequity by 31.8% during the second quarter. State of Michigan Retirement System now owns 25,966 shares of the company’s stock worth $1,523,000 after purchasing an additional 6,266 shares in the last quarter. M&T Bank Corp increased its holdings in shares of Healthequity by 20.7% in the second quarter. M&T Bank Corp now owns 17,752 shares of the company’s stock valued at $1,040,000 after buying an additional 3,048 shares in the last quarter. Sciencast Management LP bought a new position in shares of Healthequity in the second quarter valued at $863,000. DAVENPORT & Co LLC increased its holdings in shares of Healthequity by 345.9% in the second quarter. DAVENPORT & Co LLC now owns 19,663 shares of the company’s stock valued at $1,154,000 after buying an additional 15,253 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Healthequity by 30.2% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,783 shares of the company’s stock valued at $457,000 after buying an additional 1,804 shares in the last quarter. 97.31% of the stock is currently owned by institutional investors.

In other news, CEO Jon Kessler sold 100,000 shares of the firm’s stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $62.59, for a total transaction of $6,259,000.00. Following the completion of the sale, the chief executive officer now owns 405,715 shares in the company, valued at approximately $25,393,701.85. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 3.70% of the company’s stock.

Shares of HQY traded down $1.72 during midday trading on Friday, reaching $51.56. The stock had a trading volume of 800,030 shares, compared to its average volume of 1,115,102. The firm has a 50 day simple moving average of $58.13 and a 200-day simple moving average of $59.89. The company has a current ratio of 2.11, a quick ratio of 2.11 and a debt-to-equity ratio of 1.20. The firm has a market cap of $3.68 billion, a PE ratio of 1,718.67, a P/E/G ratio of 3.84 and a beta of 1.52. Healthequity Inc has a one year low of $34.40 and a one year high of $88.78.

Healthequity (NASDAQ:HQY) last posted its earnings results on Tuesday, June 2nd. The company reported $0.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.01). The company had revenue of $190.00 million for the quarter, compared to analyst estimates of $193.32 million. Healthequity had a positive return on equity of 9.48% and a negative net margin of 0.05%. The business’s quarterly revenue was up 118.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.31 EPS. As a group, research analysts forecast that Healthequity Inc will post 0.96 EPS for the current fiscal year.

Several research firms have issued reports on HQY. SVB Leerink began coverage on Healthequity in a report on Monday, April 13th. They issued a “market perform” rating and a $53.00 price target on the stock. Raymond James lowered their price objective on shares of Healthequity from $90.00 to $75.00 and set a “strong-buy” rating on the stock in a research report on Wednesday, April 8th. Guggenheim began coverage on shares of Healthequity in a research report on Tuesday, April 14th. They set a “buy” rating and a $56.00 price objective on the stock. Barrington Research reiterated a “buy” rating and set a $65.00 price objective on shares of Healthequity in a research report on Monday, June 1st. Finally, Cantor Fitzgerald lowered their price target on shares of Healthequity from $80.00 to $70.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $65.57.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Story: What is a Leveraged Buyout (LBO)?

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.